Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Goldman Sachs joins Ikonisys' series E:

This article was originally published in Clinica

Executive Summary

Ikonisys, a developer of cell-based diagnostic products, has secured $30m in a series E round. The financing came from existing shareholders in the New Haven, Connecticut firm and from new investor Goldman Sachs. The funds will enable Ikonisys to achieve further clinical milestones and launch new tests within its oncoFISH and fastFISH product lines. The oncoFISH portfolio focuses on cancer diagnostics, while the fastFISH line is dedicated to the prenatal detection of genetic disorders - both are designed to run on the Ikoniscope robotic digital microscopy platform. The company expects to launch the first two rare cell detection tests in 2008.

You may also be interested in...



QUOTED. 6 April 2020. Bethany Hills.

Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.

Health And Wellness Trademark Review 31 March, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Faster, Better? Fujitsu, Polarisqb 'Quantum-Inspired' Tech Speeds Discovery

Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.

Topics

UsernamePublicRestriction

Register

MT048637

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel